Watlington, United Kingdom

David J Chaplin

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Location History:

  • Aston Rowant, GB (2000 - 2004)
  • Watlington, CA (2006)
  • Oxford, GB (2006)
  • Watlington, GB (2005 - 2022)

Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: **David J Chaplin: A Pioneer in Tumor Therapy Innovations**

Introduction

David J Chaplin, an inventive mind based in Watlington, GB, has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 16 patents to his name, Chaplin is recognized for developing methods that enhance immunomodulating therapies against tumors. His work is pivotal in advancing medical treatments that address complex health challenges.

Latest Patents

Among his latest inventions, Chaplin's patent on the **Use of Vascular Disrupting Agents (VDAs) to enhance immunomodulating therapies against tumors** stands out. This patent outlines methods for producing an anti-tumor effect in patients suffering from cancer or tumors. The innovative approach involves administering a Vascular Disrupting Agent, such as a combretastatin agent combined with specific antibodies (CTLA-4, PD-1, PD-L1, and PD-L2), which collectively show a synergistic effect in combating tumors.

Another notable invention by Chaplin is focused on **Compositions and methods for the inhibition of cathepsins**. This patent presents a class of compounds designed to modulate cathepsin activity, particularly cathepsins K and L, which are critical in various therapeutic applications.

Career Highlights

Throughout his career, David J Chaplin has made impactful contributions to the pharmaceutical and biotechnology industries. He has worked with prominent companies such as Oxigene, Inc., and Baylor University, where he applied his expertise in developing therapeutic innovations. His extensive patent portfolio reflects his dedication to pioneering advancements that improve treatment outcomes for cancer patients.

Collaborations

In his journey of innovation, David J Chaplin has collaborated with notable professionals in the field, including Kevin G Pinney and Klaus Edvardsen. These collaborations have fostered knowledge exchange and have further propelled the development of groundbreaking therapies in the fight against cancer.

Conclusion

David J Chaplin’s innovative spirit and his contributions to cancer therapies are commendable. With a strong focus on enhancing immunomodulating treatments and the inhibition of key enzymes, his work continues to influence the medical landscape positively. His commitment to improving patient outcomes exemplifies the essence of true innovation in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…